Deals and Financings WuXi NextCODE Genomics, the newly formed genomic analysis division of China CRO/CMO WuXi PharmaTech (NYSE:WX), led a $15 million Series …
For the first full week of trading 2015, US-listed China stocks had a decent week, with the PowerShares Golden Dragon China fund (NYSE: …